ES2181670T3 - Peptidos que conservan una actividad similar a la de la tromboespondina y su utilizacion terapeutica. - Google Patents
Peptidos que conservan una actividad similar a la de la tromboespondina y su utilizacion terapeutica.Info
- Publication number
- ES2181670T3 ES2181670T3 ES92107774T ES92107774T ES2181670T3 ES 2181670 T3 ES2181670 T3 ES 2181670T3 ES 92107774 T ES92107774 T ES 92107774T ES 92107774 T ES92107774 T ES 92107774T ES 2181670 T3 ES2181670 T3 ES 2181670T3
- Authority
- ES
- Spain
- Prior art keywords
- thrombospondine
- peptides
- keep
- therapeutic use
- activity similar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
SE PROPORCIONAN COMPUESTOS Y COMPOSICIONES QUE COMPRENDEN FRAGMENTOS Y ANALOGOS SINTETICOS DE TROMBOSPONDINA HUMANA JUNTO A METODOS PARA SU UTILIZACION COMO AGENTES SIMILARES A LA TROMBOSPONDINA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70525591A | 1991-05-22 | 1991-05-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2181670T3 true ES2181670T3 (es) | 2003-03-01 |
Family
ID=24832676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92107774T Expired - Lifetime ES2181670T3 (es) | 1991-05-22 | 1992-05-08 | Peptidos que conservan una actividad similar a la de la tromboespondina y su utilizacion terapeutica. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5654277A (es) |
EP (1) | EP0514721B1 (es) |
JP (2) | JP3706151B2 (es) |
AU (1) | AU1636492A (es) |
CA (1) | CA2063055A1 (es) |
DE (1) | DE69232716T2 (es) |
ES (1) | ES2181670T3 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5610148A (en) * | 1991-01-18 | 1997-03-11 | University College London | Macroscopically oriented cell adhesion protein for wound treatment |
US5629287A (en) * | 1991-01-18 | 1997-05-13 | University College London | Depot formulations |
DE4203545A1 (de) * | 1992-02-07 | 1993-08-12 | Behringwerke Ag | Spezifische antikoerper gegen aktivierte plaettchen, ihre herstellung und ihre verwendung in diagnose und therapie |
WO1996033218A1 (en) * | 1995-04-21 | 1996-10-24 | Allelix Biopharmaceuticals Inc. | Anti-haemorrhagic peptides |
AU5699996A (en) * | 1995-06-02 | 1996-12-18 | Allelix Biopharmaceuticals Inc. | Anti-inflammatory thrombospondin-derived peptides |
US6284758B1 (en) * | 1997-08-28 | 2001-09-04 | Welfide Corporation | Angiogenesis promoters and angiogenesis potentiators |
EP1077995A1 (en) * | 1998-05-22 | 2001-02-28 | Abbott Laboratories | Antiangiogenic drug to treat cancer, arthritis and retinopathy |
US6716963B1 (en) | 1998-05-22 | 2004-04-06 | Abbott Laboratories | Peptide antiangiogenic drugs |
US6380161B1 (en) | 1999-06-21 | 2002-04-30 | Inkine Pharmaceutical Company, Inc. | Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions |
CN1297930A (zh) * | 1999-11-29 | 2001-06-06 | 上海博容基因开发有限公司 | 一种新的多肽——人凝血栓蛋白30和编码这种多肽的多核苷酸 |
US7740841B1 (en) * | 2000-01-28 | 2010-06-22 | Sunnybrook Health Science Center | Therapeutic method for reducing angiogenesis |
US7655411B2 (en) * | 2002-08-23 | 2010-02-02 | W2 Holdings, Inc. | Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer |
EP2776055B1 (en) * | 2011-08-17 | 2016-12-14 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8819209D0 (en) * | 1988-08-12 | 1988-09-14 | Research Corp Ltd | Polypeptide & dna encoding same |
US5192744A (en) * | 1990-01-12 | 1993-03-09 | Northwestern University | Method of inhibiting angiogenesis of tumors |
US5200397A (en) * | 1990-02-22 | 1993-04-06 | W. R. Grace & Co.-Conn. | Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity |
US5190918A (en) * | 1990-02-22 | 1993-03-02 | W. R. Grace & Co.-Conn. | Peptide fragments and analogs of thrombospondin and methods of use |
EP0478101B1 (en) * | 1990-09-24 | 2001-08-29 | W.R. Grace & Co.-Conn. | Therapeutic use of peptides having thrombospondin-like activity |
-
1992
- 1992-03-13 CA CA002063055A patent/CA2063055A1/en not_active Abandoned
- 1992-05-08 ES ES92107774T patent/ES2181670T3/es not_active Expired - Lifetime
- 1992-05-08 EP EP92107774A patent/EP0514721B1/en not_active Expired - Lifetime
- 1992-05-08 DE DE69232716T patent/DE69232716T2/de not_active Expired - Fee Related
- 1992-05-18 AU AU16364/92A patent/AU1636492A/en not_active Abandoned
- 1992-05-20 JP JP15119092A patent/JP3706151B2/ja not_active Expired - Fee Related
-
1995
- 1995-06-01 US US08/458,998 patent/US5654277A/en not_active Expired - Lifetime
-
2005
- 2005-06-08 JP JP2005168928A patent/JP2005272480A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US5654277A (en) | 1997-08-05 |
DE69232716D1 (de) | 2002-09-12 |
EP0514721B1 (en) | 2002-08-07 |
DE69232716T2 (de) | 2002-11-28 |
EP0514721A1 (en) | 1992-11-25 |
AU1636492A (en) | 1992-11-26 |
JP2005272480A (ja) | 2005-10-06 |
CA2063055A1 (en) | 1992-11-23 |
JPH05178757A (ja) | 1993-07-20 |
JP3706151B2 (ja) | 2005-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2181670T3 (es) | Peptidos que conservan una actividad similar a la de la tromboespondina y su utilizacion terapeutica. | |
NO831575L (no) | Menneskevev-plasminogenaktivator | |
BR8803899A (pt) | Composicao para cuidados da pele | |
ES2120274T3 (es) | Utilizacion de un extracto de una bacteria filamentosa no fotosintetica y composicion. | |
ES2167592T3 (es) | Preparaciones medicamentosas que contienen un enantiomero de bromuro de ipratropio con duracion de la accion prolongada. | |
UY24805A1 (es) | Peptidos y compuestos que se enlazan al receptor de la trombopoyetina | |
ES2116986T3 (es) | Composiciones de metal-peptidos y metodos cosmeticos para estimular el crecimiento del cabello. | |
ES2159382T3 (es) | Compuestos estilbenicos con grupo adamantilo, composiciones que los contienen y utilizaciones. | |
ES2176795T3 (es) | Composiciones a base de esfingomielanasa y su utilizacion. | |
ES2045479T3 (es) | Metodo cosmetico que utiliza un extracto de las partes aereas de cichorium intybus l. | |
BR9914925A (pt) | Processos para reduzir o crescimento de cabelo de mamìfero, para tratar uma área de pele, e, para produzir uma composição para inibir crescimento do cabelo de mamìfero, uso de um inibidor de fosfatase alcalina, e, composição usada para inibir crescimento de cabelo de mamìfero. | |
ES2176487T3 (es) | Composiciones cosmeticas y/o farmaceuticas antipruriginosas compuestas de uno o varios anestesicos locales suaves y uno o varios astringentes. | |
NZ191630A (en) | Medicated animal feeds containing liver meal | |
ES2059721T3 (es) | Composicion para el tratamiento de la piel. | |
ES2038270T3 (es) | Preparaciones topicas sebosupresoras. | |
ES2059320T3 (es) | Nuevos diarilalcanoides que tienen actividad como inhibidores de lipoxigenasa. | |
AR004052A1 (es) | Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico | |
ES2176495T3 (es) | Utilizacion de un antagonista de la bradiquinina, destinada a inducir y/o estimular el crecimiento de los cabellos y/o frenar su caida. | |
PT817625E (pt) | Composicoes para o tratamento de pele fotodanificada, compreendendo um antagonista de rar-alfa e um retinoide multi-selectivo | |
ES2169420T3 (es) | Compuestos triciclicos utiles para inhibir la funcion de la proteina g y para tratar enfermedades proliferativas. | |
PT952975E (pt) | Compostos bi-aromaticos ligados por um radical hetero-etinileno e composicoes farmaceuticas e cosmeticas que os contem | |
AR034065A1 (es) | Productos capilares que contienen aceites naturales con esteroles y acidos grasos insaturados y empleo de aceites naturales y de preparaciones | |
ES2159357T3 (es) | Derivados terpenoides (sarcodictinas) utiles como agentes antitumorales. | |
DK0613368T3 (da) | Hudregenererende kosmetisk sammensætning | |
MX9307203A (es) | COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS. |